Paper Details 
Original Abstract of the Article :
Five percent fine granule preparation of cefdinir (CFDN, FK482) was administered to 30 patients with acute febrile respiratory tract infections (RTI) at 4.9-21.1 mg/kg/day divided into 3 portions. And 10% fine granule preparation of CFDN was also administered to 11 patients with acute febrile RTI an...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/1762166

データ提供:米国国立医学図書館(NLM)

Cefdinir: A Promising Antibiotic for Pediatric Infections

This research investigates the efficacy and safety of cefdinir (CFDN) in treating pediatric infections, specifically acute febrile respiratory tract infections (RTI). The study involves the administration of cefdinir in fine granule form to children with various RTI diagnoses, including pharyngitis, tonsillitis, pneumonia, and urinary tract infections. The results demonstrate good clinical effects and bacteriological eradication for a significant proportion of patients, with cefdinir showing efficacy against various bacterial strains. The study also highlights the generally well-tolerated nature of cefdinir, with only minor side effects reported. This research provides evidence for the potential of cefdinir as a promising therapeutic option for treating pediatric infections.

Cefdinir: A Potential Oasis in the Desert of Pediatric Infections

This study offers a beacon of hope for parents and healthcare providers dealing with pediatric infections. Imagine a desert landscape, where a child is struggling with a stubborn infection. Cefdinir, like a refreshing oasis, offers a potential path towards recovery, effectively combating bacterial strains and providing relief from symptoms. This research highlights the potential of cefdinir as a valuable tool in treating pediatric infections.

Protecting Our Youngest: Advancing Treatment for Pediatric Infections

This research underscores the importance of developing effective and safe treatments for pediatric infections, ensuring the well-being of our youngest and most vulnerable populations. It's like creating a safe haven in the desert, where children can receive the care they need to thrive. This study encourages continued research and development of antibiotics and therapeutic strategies that can improve the health and well-being of children, giving them the best possible chance to overcome infections and grow strong.

Dr.Camel's Conclusion

This research provides encouraging evidence for the efficacy and safety of cefdinir in treating pediatric infections. It's like discovering a hidden oasis in the desert, offering a potential solution for families facing this challenge. This study encourages continued research and development of antibiotics that can effectively and safely treat pediatric infections, ensuring the health and well-being of our youngest and most vulnerable populations.

Date :
  1. Date Completed 1992-02-12
  2. Date Revised 2018-11-30
Further Info :

Pubmed ID

1762166

DOI: Digital Object Identifier

1762166

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.